Cargando…

Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases

BACKGROUND: To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province. METHODS: Thirty-four indicators were selected b...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreano, Anita, Valsecchi, Maria Grazia, Russo, Antonio Giampiero, Siena, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830847/
https://www.ncbi.nlm.nih.gov/pubmed/33494836
http://dx.doi.org/10.1186/s13690-021-00528-0
_version_ 1783641506207236096
author Andreano, Anita
Valsecchi, Maria Grazia
Russo, Antonio Giampiero
Siena, Salvatore
author_facet Andreano, Anita
Valsecchi, Maria Grazia
Russo, Antonio Giampiero
Siena, Salvatore
author_sort Andreano, Anita
collection PubMed
description BACKGROUND: To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province. METHODS: Thirty-four indicators were selected by revision of main guidelines by cancer epidemiologists, and then evaluated by a multidisciplinary panel of clinicians involved in lung cancer care and working on the pathway of lung cancer diagnosis and treatment in the Lombardy region, Italy. With a modified Delphi method, they assessed for each indicator the content validity as a quality measure of the care pathway, the degree of modifiability from the health professional, and the relevance to the health professional. Feasibility was assessed using the cancer registry and the routine health records of the Lombardy region. Feasible indicators were then calculated in the cohort of lung cancer patients diagnosed in 2007–2012 derived from the cancer registry of the Milan Province. Criterion validity was assessed reviewing clinical records of a random sample of 114 patients (threshold for acceptable discordance ≤20%). Finally, reliability was evaluated at the provider level. RESULTS: Initially, 34 indicators were proposed for evaluation in the first Delphi round. Of the finally 22 selected indicators, 3 were not feasible because the required information was actually not available. The remaining 19 were calculated on the pilot cohort. After assessment of criterion validity (3 eliminated), 16 indicators were retained in the final set and evaluated for reliability. CONCLUSION: The developed and piloted set of indicators is now available to implement and monitor, over time, quality initiatives for lung cancer care in the studied health system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00528-0.
format Online
Article
Text
id pubmed-7830847
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78308472021-01-26 Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases Andreano, Anita Valsecchi, Maria Grazia Russo, Antonio Giampiero Siena, Salvatore Arch Public Health Research BACKGROUND: To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province. METHODS: Thirty-four indicators were selected by revision of main guidelines by cancer epidemiologists, and then evaluated by a multidisciplinary panel of clinicians involved in lung cancer care and working on the pathway of lung cancer diagnosis and treatment in the Lombardy region, Italy. With a modified Delphi method, they assessed for each indicator the content validity as a quality measure of the care pathway, the degree of modifiability from the health professional, and the relevance to the health professional. Feasibility was assessed using the cancer registry and the routine health records of the Lombardy region. Feasible indicators were then calculated in the cohort of lung cancer patients diagnosed in 2007–2012 derived from the cancer registry of the Milan Province. Criterion validity was assessed reviewing clinical records of a random sample of 114 patients (threshold for acceptable discordance ≤20%). Finally, reliability was evaluated at the provider level. RESULTS: Initially, 34 indicators were proposed for evaluation in the first Delphi round. Of the finally 22 selected indicators, 3 were not feasible because the required information was actually not available. The remaining 19 were calculated on the pilot cohort. After assessment of criterion validity (3 eliminated), 16 indicators were retained in the final set and evaluated for reliability. CONCLUSION: The developed and piloted set of indicators is now available to implement and monitor, over time, quality initiatives for lung cancer care in the studied health system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00528-0. BioMed Central 2021-01-25 /pmc/articles/PMC7830847/ /pubmed/33494836 http://dx.doi.org/10.1186/s13690-021-00528-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Andreano, Anita
Valsecchi, Maria Grazia
Russo, Antonio Giampiero
Siena, Salvatore
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases
title Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases
title_full Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases
title_fullStr Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases
title_full_unstemmed Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases
title_short Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases
title_sort indicators of guideline-concordant care in lung cancer defined with a modified delphi method and piloted in a cohort of over 5,800 cases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830847/
https://www.ncbi.nlm.nih.gov/pubmed/33494836
http://dx.doi.org/10.1186/s13690-021-00528-0
work_keys_str_mv AT andreanoanita indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases
AT valsecchimariagrazia indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases
AT russoantoniogiampiero indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases
AT sienasalvatore indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases
AT indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases